News | Magnetic Resonance Imaging (MRI) | July 06, 2021

Company’s smallest, most lightweight scanner uses less than 1 liter of helium and no quench pipe

 Siemens Healthineers announced the U.S. Food and Drug Administration (FDA) clearance of the Magnetom Free.Max, a new High-V magnetic resonance (MR) scanner that combines a 0.55 Tesla (0.55T) field strength with deep learning technologies and advanced image processing

July 5, 2021 — Siemens Healthineers announced the U.S. Food and Drug Administration (FDA) clearance of the Magnetom Free.Max, a new High-V magnetic resonance (MR) scanner that combines a 0.55 Tesla (0.55T) field strength with deep learning technologies and advanced image processing. By doing so, the scanner broadens the range of MR clinical applications and provides customers with the inherent clinical benefits of a mid-field MR scanner. The first and only 80 cm wide-bore system available, the Magnetom Free.Max also facilitates MR scanning for extremely obese and claustrophobic patients, enhancing the patient experience.

At less than 3.5 tons and less than 80 inches high, the Magnetom Free.Max is the most lightweight, compact whole-body scanner ever offered by Siemens Healthineers. Its reduced size permits installation with minimal structural modifications. And where MR scanners typically require several hundred liters of helium and a quench pipe for cooling purposes, the new magnet of the Magnetom Free.Max uses less than 1 liter of helium, reducing lifecycle and infrastructure costs. For these reasons, the customer can install the Magnetom Free.Max in areas where an MR scanner could not be housed previously.

The Magnetom Free.Max leverages the company’s latest image processing and artificial intelligence workflow innovations. Deep Resolve is a set of algorithms that performs targeted denoising and uses deep learning to deliver sharper, higher-resolution images. myExam Companion, a comprehensive workflow solution that incorporates elements of artificial intelligence, helps the user navigate the examination to efficiently achieve consistent, high-quality results, regardless of user experience level, patient, or throughput.

“Siemens Healthineers is proud to offer the Magnetom Free.Max, which brings MR to new clinical fields with innovative digital technology, new siting features, and image quality that was once realized only at higher field strengths,” said Jane Kilkenny, Vice President of Magnetic Resonance at Siemens Healthineers North America. “The scanner’s comparatively low weight and size can open the door to MR utilization in orthopedic centers, emergency rooms, outpatient centers, and even intensive care units.”

For more information: siemens-healthineers.us/free-max


Related Content

Feature | Radiology Imaging

View the September/October digital edition of Imaging Technology News (ITN), including links to videos, comparison ...

Time September 29, 2022
arrow
News | Pediatric Imaging

September 29, 2022 — According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR ...

Time September 29, 2022
arrow
News | Radiology Imaging

September 27, 2022 — UK Biobank, the large-scale biomedical database and research resource, together with the Medical ...

Time September 27, 2022
arrow
News | Point-of-Care Ultrasound (POCUS)

September 27, 2022 — Fujifilm Sonosite, Inc. – the world leader in point-of-care ultrasound (POCUS) solutions – has ...

Time September 27, 2022
arrow
News | Prostate Cancer

September 26, 2022 — Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game ...

Time September 26, 2022
arrow
News | Artificial Intelligence

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech ...

Time September 22, 2022
arrow
News | Contrast Media

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
Feature | Breast Imaging | By Christine Book

Findings from a clinical trial that used artificial intelligence (AI) in an effort to reduce false positives on breast ...

Time September 21, 2022
arrow
News | Contrast Media

September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration ...

Time September 21, 2022
arrow
News | Coronavirus (COVID-19)

September 20, 2022 — Children and adolescents who have either recovered from COVID-19 or have long COVID show persistent ...

Time September 20, 2022
arrow
Subscribe Now